BANF1, PLOD3, SF3B4 as Early-Stage Cancer Decision Markers and Drivers of Hepatocellular Carcinoma

Hepatology - United States
doi 10.1002/hep.29606
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Comparison of Urinary and Serum CA 19-9 as Markers of Early Stage Urothelial Carcinoma

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2013English

Evaluation of Cancer-Associated Fibroblasts Markers in Hepatocellular Carcinoma

The Medical Journal of Cairo University
2019English

Gastric Metastasis of Hepatocellular Carcinoma Mimicking Early Gastric Cancer

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

Study of P53 Gene Mutations as a New Early Diagnostic Markers of Hepatocellular Carcinoma in Egyptian Patients

Madridge Journal of Oncogenesis
2018English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Screening and Early Diagnosis of Hepatocellular Carcinoma

ACTUAL INFECTOLOGY
2018English

Letter: Is Microwave Ablation Superior to Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Serum Exosomal microRNAs Combined With Alpha-Fetoprotein as Diagnostic Markers of Hepatocellular Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Novel Endothelial Cell Markers in Hepatocellular Carcinoma

Modern Pathology
Forensic MedicinePathology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy